Trial Profile
Prospective evaluation on the role exerted by the association of ethinylestradiol (0,03 mg) plus clormadinone acetate (2 mg) or ethinylestradiol (0,02 mg) plus desogestrel (0,15 mg) on insulin sensitivity.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Apr 2012
Price :
$35
*
At a glance
- Drugs Ethinylestradiol/chlormadinone (Primary) ; Ethinylestradiol/desogestrel
- Indications Pregnancy
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.